WHO ICTRP trial
The value of 18F-FDG PET/CT radiomics combined with clinicopathological features…
ChiCTR2300077761 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR2300077761 |
|---|---|
| Public title | The value of 18F-FDG PET/CT radiomics combined with clinicopathological features to predict molecular typing and Ki67 expression of breast cancer |
| Scientific title | The value of 18F-FDG PET/CT radiomics combined with clinicopathological features to predict molecular typing and Ki67 expression of breast cancer |
| Primary sponsor | The First Affiliated Hospital of Soochow University |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Diagnostic test |
| Phase | Retrospective study |
| Countries | China |
| Conditions | breast cancer |
| Interventions | Gold Standard:Pathological diagnosis;Index test:18F-FDG PET-CT |
| Registration date | Nov 18, 2023 |
| Target size | Target condition:134;Difficult condition:0 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: